Andrew N. Liveris

Andrew N. Liveris has 64 filings between February 17, 2016 and June 9, 2025, at four US companies: DuPont de Nemours, Inc. (39), DOW Chemical Co /DE/ (17, CEO and Chairman), Lucid Group, Inc. (7, Director) and International Business Machines Corp (1, Director).

Sales weigh heavily: 16, all at DuPont, for EUR 61.0 million in total with a median of EUR 4,198,643. The three largest are December 1, 2017 (EUR 9,084,532), November 29, 2017 (EUR 6,071,389) and February 26, 2018 (EUR 6,006,287). A single purchase is on file, at IBM on November 2, 2020, for EUR 257,515; it makes up 6% of the market trades. The record adds 16 share grants, 18 option exercises and 13 filings of another kind.

Activity is concentrated: 29 filings in 2017 and 20 in 2018, against one a year from 2022 on. No filing falls in the last twelve months. Publication follows the trade by a median of 2 days.

Liveris has 16, 9 and 7 own market trades within 30 days of colleagues at DuPont de Nemours, Inc., in that order, every one in the same direction. Colleagues in order: Charles J. Kalil, James C. Collins Jr. and Jeanmarie F. Desmond.